Last reviewed · How we verify

NCT06031506

Management of Severely Atrophied Maxillary Ridge Using Quad Zygomatic Implants

Status unknown NA Last updated 11 September 2023
What this trial tests

NA trial testing Implant supported hybrid maxillary prosthesis in Prosthesis Durability in 15 participants. Status unknown.

Timeline
15 December 2022
Primary endpoint
7 March 2023
16 June 2024

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date15 December 2022
Primary completion7 March 2023
Estimated completion16 June 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 45 to 70, any sex, with Prosthesis Durability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study will aim to compare and evaluate zygomatic implant stability, occlusal contact, and bone level changes around dental implants

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prosthesis Durability

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing